Siga Technologies, Inc.
UnclaimedPharmaceutical Preparation ManufacturingNew York, NY
Founded
1995
Primary NAICS
325412
CAGE code
1V4X4
Federal awards
$363.6M
Overview
SIGA Protecting humanity against infectious diseases
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $2,068,321 | 2 |
| 2025 | Department of Health and Human Services | $53,123,168 | 3 |
| 2025 | Department of Defense | $0 | 1 |
| 2024 | Department of Health and Human Services | $112,552,320 | 3 |
| 2024 | Department of Defense | $10,091,475 | 3 |
| 2023 | Department of Health and Human Services | $138,169,509 | 2 |
| 2023 | Department of Defense | $5,510,426 | 2 |
| 2022 | Department of Health and Human Services | $29,432,278 | 10 |
| 2022 | Department of Defense | $12,619,832 | 3 |